title: Expression of constitutively activated NF-κB/mTORC pathway proteins and response to CHOP with bortezomib in a patient with angioimmunoblastic peripheral T-cell lymphoma.
authors.affiliation: Department of Pathology and Laboratory Medicine, The University of Texas at Houston, Houston, TX. Electronic address: andres.e.quesada@uth.tmc.edu.
authors.forename: Andrés E
authors.initials: AE
authors.lastname: Quesada
authors.affiliation: Department of Internal Medicine, Division of Oncology, The University of Texas at Houston, Houston, TX.
authors.forename: Adan
authors.initials: A
authors.lastname: Rios
authors.affiliation: Department of Pathology and Laboratory Medicine, The University of Texas at Houston, Houston, TX.
authors.forename: Robert E
authors.initials: RE
authors.lastname: Brown
authors.affiliation: Department of Pathology and Laboratory Medicine, The University of Texas at Houston, Houston, TX.
authors.forename: Nghia D
authors.initials: ND
authors.lastname: Nguyen
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016411:Lymphoma, T-Cell, Peripheral / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism*; D049268:Positron-Emission Tomography; D011241:Prednisone / Q000627:therapeutic use; D011719:Pyrazines / Q000008:administration & dosage*; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases / Q000378:metabolism*; D016896:Treatment Outcome; D047368:Tumor Burden; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D001897:Boronic Acids; D016328:NF-kappa B; D011719:Pyrazines; D014750:Vincristine; D000069286:Bortezomib; D004317:Doxorubicin; D003520:Cyclophosphamide; D058570:TOR Serine-Threonine Kinases; D011241:Prednisone
keywords: Chemoresistance; Hematopathology; Immunohistochemistry; Morphoproteomics; Oncoproteomics